Opinion
2012-1523 2012-1524 2012-1555 2012-1556 2012-1557 2012-1545 2012-1546 2012-1590 2012-1591 2012-1592 2012-1566 2012-1596 2012-1597 2012-1598 2012-1599
10-15-2012
THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND NEW YORK UNIVERSITY, Plaintiff-Cross Appellant, AND GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant, MYLAN PHARMACEUTICALS INC., Plaintiff-Appellant, v. GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Defendants-Cross Appellants, AND SUPERNUS PHARMACEUTICALS, INC., Defendant-Appellee. THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee, AND NEW YORK UNIVERSITY, Plaintiff-Cross Appellant, AND GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants v. IMPAX LABORATORIES, INC., Defendant-Appellant. GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Cross Appellants, AND SUPERNUS PHARMACEUTICALS, INC., Plaintiff-Appellee, v. LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants. THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, Plaintiff, AND NEW YORK UNIVERSITY, Plaintiff-Appellant, AND GALDERMA LABORATORIES INC. AND GALDERMA LABORATORIES, L.P., Plaintiffs-Appellants v. LUPIN LIMITED AND LUPIN PHARMACEUTICALS, INC., Defendants-Cross Appellants.
NOTE: This order is nonprecedential.
Appeals from the United States District Court for the District of Delaware in case nos. 09-CV-0184 and 10-CV-0892, Judge Leonard P. Stark.
Appeals from the United States District Court for the
District of Delaware in case nos. 09-CV-0703 and 11-CV-
0477, Judge Leonard P. Stark.
Appeals from the United States District Court for the
District of Delaware in case no. 10-CV-1112, Judge Leonard P. Stark.
Appeals from the United States District Court for the
District of Delaware in case no. 09-CV-0483, Judge Leonard P. Stark.
ON MOTION
ORDER
Upon consideration of Galderma Laboratories Inc., et al.'s unopposed motions to consolidate the above captioned appeals and set the briefing schedule,
IT IS ORDERED THAT:
(1) The motions are granted. Mylan Pharmaceuticals, Inc., Impax Laboratories, Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc.'s principal briefs are due October 1, 2012. Galderma Laboratories Inc., Galderma Laboratories, L.P., Supernus Pharmaceuticals, Inc., and New York University's principal and response briefs are due November 13, 2012. Mylan, Impax, and Lupin's re- sponse/reply briefs are due December 26, 2012. Galderma and New York University's reply briefs are due January 11, 2013.
(2) The revised official caption is reflected above.
FOR THE COURT
_________________
Jan Horbaly
Clerk
s26